XML 35 R25.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Quantitative Disclosure of the Fair Value for Each Major Category of Assets and Liabilities
The following financial instruments are remeasured at fair value on a recurring basis:
Fair Value Measurements as of
March 31, 2022December 31, 2021
Cash Flow Hedges: (a)
Level 1Level 2Level 3Level 1Level 2Level 3
Derivative interest rate swaps (b)(c)$— $12,109 $— $— $(4,322)$— 
(a)During the twelve months subsequent to March 31, 2022, an estimated $1,503 of derivative interest rate assets recognized in accumulated comprehensive income (loss) will be reclassified into earnings.
(b)The Company's derivative assets or liabilities are recognized as a part of deferred costs and other assets, net or other liabilities, respectively. IAGM's derivative assets or liabilities are recognized as a part of investment in unconsolidated entities.
(c)As of March 31, 2022 and December 31, 2021, the Company determined that the credit valuation adjustments associated with nonperformance risk are not significant to the overall valuation of its derivatives. As a result, the Company's derivative valuations in their entirety are classified as Level 2 of the fair value hierarchy.
Schedule of Fair Value of Financial Instruments Presented at Carrying Values
The table below summarizes the estimated fair value of financial instruments presented at carrying values in the Company's condensed consolidated financial statements as of March 31, 2022 and December 31, 2021:
March 31, 2022December 31, 2021
Carrying ValueEstimated Fair ValueCarrying ValueEstimated Fair Value
Mortgages payable$140,829 $135,024 $105,955 $104,938 
Term loans$400,000 $400,644 $400,000 $400,470 
Revolving line of credit$136,000 $136,329 $31,000 $31,062